Moderna (MRNA) fell 6.8% on 10 Nov 2026. The stock closed at $250.83, against $269.00 the session before.
That puts the company's market value at about $101.5B. The 52-week range is $22.28 to $280.80, so the stock now sits 10.7% below the top of it.
Over the past 52 weeks the shares have moved +918.6%.
Figures from Yahoo Finance at the time of writing. Not investment advice.